MedTrace Logo

Prognostic Value of Peak Lactate During Cardiopulmonary Bypass in Adult Cardiac Surgeries

NCT03934892 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2019-05-02

No results posted yet for this study

Summary

Tissue hypoperfusion during cardiopulmonary bypass (CPB) affects cardiac surgical outcomes. Lactate, an end product of anaerobic glycolysis from oxygen deficit, is an obtainable marker of tissue hypoxia. The investigators aimed to determine the value of blood lactate level during CPB in adult cardiac surgeries in predicting outcomes.

The investigators retrospectively reviewed the patients underwent cardiac surgeries with CPB from January 2015 to December 2015. The patient's characteristics, pre-operative status, surgical type, and intra-operative lactate levels were collected. The outcomes were in-hospital mortality and complications. Receiver operating characteristics (ROC) curves were used to assess the ability of peak lactate level during CPB to predict in-hospital mortality.

Conditions

  • Cardiopulmonary Bypass
  • Lactate

Interventions

DIAGNOSTIC_TEST

serum lactate

check lactate levels during cardiopulmonary bypass in adult cardiac operations

Sponsors & Collaborators

  • Hualien Tzu Chi General Hospital

    lead OTHER

Principal Investigators

  • Yi-tso Cheng, MD · Hualien Tzu Chi General Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03934892 on ClinicalTrials.gov